|
Although at odds over issues like trade and Taiwan, the U.S. and Chinese leaders met in Beijing with a show of friendly gestures.
|
|
U.S. President Donald Trump is in Beijing for a highly anticipated summit with his Chinese counterpart President Xi Jinping. It is the first U.S. state visit to China since 2017, during Trump's first administration. Trade, the Iran war, artificial intelligence and the fate of Taiwan are some of the issues being discussed, although it's not clear if any new agreements are likely. Trump traveled to China with Secretary of State Marco Rubio, Defense Secretary Pete Hegseth and Treasury Secretary Scott Bessent, along with a delegation of top U.S. executives including Apple CEO Tim Cook, Elon Musk of Tesla and Jensen Huang of Nvidia.
The summit comes after years of rising hostility between the two superpowers, but leaders recognize the importance of improving the bilateral relationship, says Zhao Hai, director of international political studies at the Institute of World Economics and Politics in Beijing. "This is a very critical historical moment [at] a crossroad, and both sides now are working together to establish a stable relationship that will have a global ramification," he says.
We also speak with Jake Werner, a historian of modern China and director of the East Asia Program at the Quincy Institute for Responsible Statecraft. He says the U.S.-Israeli war on Iran and the resulting economic chaos have strengthened China's position.
"China has ties to all the countries in the region. It has acted in the past to help broker the normalization of relations between Saudi Arabia and Iran," says Werner. "So it has some experience in this realm, sort of acting as a broker towards peace."
|
RELATED ARTICLES | | |
|
(Second column, 3rd story, link)
Drudge Report Feed needs your support! Become a Patron
|
RELATED ARTICLES | | |
|
Political turmoil continued in Westminster on Thursday after Health Secretary Wes Streeting resigned Starmer's government saying he had "lost confidence" in his leadership.
|
|
Sir Keir battles to save his job, as Health Secretary Wes Streeting is thought to be plotting a leadership challenge potentially as early as Thursday.
|
|
Salah Sarsour, a prominent Palestinian immigrant, green card holder and president of Wisconsin's largest mosque, the Islamic Society of Milwaukee, has been locked up in an ICE jail since late March. Despite his lawful permanent resident status, the government says he could be subject to deportation for failing to disclose a conviction by Israeli military authorities when he was a teenager in the occupied West Bank. Sarsour says he never understood the charges presented against him in Hebrew and that he was tortured in Israeli custody. Supporters view the case as an escalation of the Trump administration's crackdown on Pro-Palestinian speech. Munjed Ahmad, a member of Salah Sarsour's legal team, says, "Salah's case will be a litmus test. Will we allow the administration to gut those rights and to strip people from their free speech?"
Ahmad is joined by Sarsour's son Kareem, who calls Trump's federal immigration agents "kidnappers" and says his family initially had no idea what had happened to his father. While incarcerated, Salah Sarsour missed the birth of his ninth grandchild. "He's a community pillar," says Kareem Sarsour. "The entire thing shook us as a family."
|
|
Trump's commissioner of the Food and Drug Administration, Dr. Martin Makary, has resigned. During Makary's 13-month tenure, he attempted to split the difference between Health and Human Services Secretary Robert F. Kennedy Jr.'s Make America Healthy Again agenda and a more traditional approach to regulation, ultimately angering both camps. "Nobody was happy with what he did," says Dr. Aaron Kesselheim, a professor of medicine at Harvard Medical School.
Shortly before his resignation, Makary had drawn the ire of President Trump for attempting to block the approval of fruit-flavored vapes, and anti-abortion groups for not placing harsher restrictions on the abortion pill mifepristone. But even before Makary took the helm, mass layoffs and the loss of scientific expertise had already thrown the FDA, which has oversight powers extending to more than a fifth of the U.S. economy, in turmoil.
The FDA's deputy commissioner for food, Kyle Diamantis, will now assume Makary's position in an acting capacity. Diamantas, a personal friend of Donald Trump Jr., does not have a background in medicine. The abrupt leadership shakeup is worrisome for the future of health and medicine in the United States, says Dr. Robert Steinbrook, the health research director at watchdog organization Public Citizen. "We need a strong public health agency," he explains. "[But] when you pick them apart for particular theories and the idiosyncrasies of the Health and Human Services secretary, you destroy things which take years, if not decades, to rebuild."
|
|
The U.S. Supreme Court has effectively gutted Section 2 of the Voting Rights Act, the last remaining major provision of the landmark 1965 law that was a crowning achievement of the civil rights movement.
In a 6-3 decision along partisan lines, a majority of justices ruled Wednesday that Louisiana must redraw a congressional map that was designed to create a second majority-Black district in the state, where African Americans have long faced racial segregation and barriers to voting. They said the electoral map "relied too heavily on race," an interpretation that is set to usher in another wave of redistricting across the South to help Republicans win more seats in Congress.
"This is central to whether or not we maintain a multiracial democracy in this country," says lawyer and civil rights activist Maya Wiley, head of the Leadership Conference on Civil and Human Rights. She calls Wednesday's ruling "a free pass to discriminate."
|
|
